Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Annual coverage of the lot testing programme (referred to reported RDT sales)

From: Global survey of malaria rapid diagnostic test (RDT) sales, procurement and lot verification practices: assessing the use of the WHO–FIND Malaria RDT Evaluation Programme (2011–2014)

  Evaluated by lot testinga Delivered (reported sales)b Percentage of market coveragec (%)
2011
 Lots 334 1310 25
 RDTs 68,842,861 121,442,342 57
2012
 Lots 480 1525 31
 RDTs 105,454,077 172,699,367 61
2013
 Lots 908 1708 53
 RDTs 208,914,128 254,209,335 82
2014
 Lots 782 1752 45
 RDTs 211,334,091 297,731,435 71
(2011–14)
 Lots 2504 6295 40
 RDTs 594,545,158 846,082,479 70
  1. aNumber of lots or RDTs that underwent the WHO-FIND malaria RDT lot testing, as per the lot testing database
  2. bNumber of lots or RDTs sold as per the survey data gathered from the RDT manufacturers
  3. cCoverage of the Lot Testing programme, estimated by calculating the percentage of lots or RDTs that have been lot tested, relative to the total number of lots or RDTs sold in a given year